Abstract:Introduction Thrombopoietin (Tpo) is critical for the maintenance of hematopoi-etic stem and progenitor cells and is also the primary regulator of megakaryocyte development. 1,2 The binding of Tpo to its receptor, c-Mpl, causes associated Janus kinase 2 (Jak2) activation, which in turn phosphorylates (activates) several downstream effectors including signal transducers and activators of transcription (STAT) 3 and 5, mitogen-activated protein kinase (MAPK), phosphotidylinositol-3-kinase (PI3-K), and protein kinase C (PKC). 3-7 Activation of these pathways promotes proliferation and survival in c-Mpl– expressing cell lines and hematopoietic progenitor cells, in addition to megakaryocyte lineage differentiation and maturation. 8-11 It is critical that Tpo signal transduction is stringently controlled to prevent uncontrolled proliferation. Suppressors of cytokine signal-ing (SOCS) proteins, phosphatases, and negative regulators such FAK, Lnk, and Lyn have all been shown to down-modulate Tpo-induced signaling. 12-15 However, the most effective method of regulating Tpo signaling is by controlling expression of c-Mpl on the plasma membrane. Tpo-mediated c-Mpl endocytosis, recycling , and degradation are rapid mechanisms to control signaling longevity and represent a mechanism that regulates Tpo signaling without new protein expression. The principal mechanism of receptor-mediated endocytosis in eukaryotic cells is the clathrin-coated vesicle. 16 Soluble clathrin molecules self-assemble and are recruited to the plasma membrane, where they form lattice structures and interact with transmembrane receptors via adaptor proteins (APs), such as AP2, to form clathrin-coated pits. 17,18 These pits then further invaginate before finally budding from the membrane to form clathrin-coated vesicles. AP2 is a heterotetramer composed of ␣2, ␤2, ␮2, and ␴2 subunits. The ␣2 and ␤2 subunits localize AP2 to the membrane, recruit endocytic accessory proteins, and bind clathrin heavy chain. 19-21 Transmembrane proteins are associated with the AP2-clathrin complex via the ␮2 domain, which binds directly to cytoplasmic YXX⌽ (where X ϭ any amino acid and ⌽ ϭ bulky hydrophobic residue) and [DE]XXX-L[IL] motifs. 22,23 To ensure that AP2 specifically associates with membrane-bound proteins, phosphorylation of 156 Thr in the ␮2 subunit results in a conformational change in AP2, dramatically increasing the affinity of ␮2 for YXX⌽ motifs. 24,25 156 Thr is phosphorylated by adaptor-associated kinase 1 (AAK1), 26 the activity of which is maximized by its association with clath-rin, 27,28 ensuring that AP2–cargo protein interactions are initiated only at the plasma membrane. In addition to being an endocytic signal, YXX⌽ motifs located between 6 to 9 amino acids from the transmembrane domain mediate targeting of cargo protein …

Aggregation of the Intracellular Domain of the Human Thrombopoietin Receptor C-Mpl.

Screening of Proteins That Interact with Human Thrombopoietin Receptor C-Mpl Using Yeast Two-Hybrid System

SGK and 14-3-3 protein are involved in the serine/ threonine phosphorylation mechanism for TPO/MPL signal transduction

Upregulation of Proto-Oncogene C-Mpl by Interleukin-13 in Dami Cells

Cloning of a Full Length cDNA of Human Thrombopoietin Receptor c-Mpl and Construction of Engineered Cells that Stably Express c-mpl

Characterization of the Human Thrombopoietin Gene Promoter

Identification of Human T Cell Receptor Γδ-Recognized Epitopes/Proteins Via CDR3δ Peptide-based Immunobiochemical Strategy

Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases

Yrrl Motifs in the Cytoplasmic Domain of the Thrombopoietin Receptor Regulate Receptor Internalization and Degradation Thrombopoietin (tpo), Acting through the C-mpl Receptor, Promotes the Survival and Proliferation of Hematopoietic Stem and Progenitor Cells and Drives Megakaryo- Cyte Differentiatio

Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease

Cryo-EM structure of the extracellular domain of murine Thrombopoietin Receptor in complex with Thrombopoietin

Neutralization of Biological Activity and Inhibition of Receptor Binding by Antibodies Against Human Thrombopoietin

Expression and Bioactivity of Recombinant Human Serum Albumin and Dtmp Fusion Proteins in CHO Cells

A critical role for the regulation of Syk from agglutination to aggregation in human platelets

Adiponectin Promote TPO Response for Treating ITP by Relating Rab6A-myosin9 Trafficking Vehicle Carrying C-Mpl to Cell Surface

Expression, Purification, and Characterization of A Novel Recombinant Fusion Protein, Rhtpo/Scf, in Escherichia Coli

Requirement Of Tpo/C-Mpl For Il-17a-Induced Granulopoiesis And Megakaryopoiesis

Functional Expression of Human Serum Albumin-Tandem Thrombopoietin Mimetic Peptide Fusion Protein As A Novel Thrombopoietin Analog in Pichia Pastoris

Expression, Refolding, and Characterization of Recombinant Thrombopoietin/stem Cell Factor Fusion Protein in Escherichia Coli

Fluorescence Labeling of a Cytokine with Desthiobiotin-Tagged Fluorescent Puromycin

A Novel Thrombopoietin–stem‐cell Factor Fusion Protein Possesses Enhanced Potential in Stimulating Megakaryocyte Proliferation and Differentiation